GlassScriptPhysician profile
Paul V Williams
NPI 1306872551
$7,233.79
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,001 · 2020: $15.76 · 2021: $33.10 · 2023: $145 · 2024: $39.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $184.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $6,586.06 | 2019 | |
| Genzyme Corporation | $194.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $149.50 | 2019-2020 | |
| Biocryst US Sales Co., LLC | $114.08 | 2023 | Orladeyo |
| Novartis Pharmaceuticals Corporation | $76.42 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.85 | 2019-2021 | |
| Genentech USA, INC. | $30.89 | 2023 | Xolair |
| Csl Behring | $18.43 | 2019 | |
| Glaxosmithkline, LLC. | $14.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.